1. Donehower LA (1992) Mice Deficient for P53 Are Developmentally Normal but Susceptible to Spontaneous Tumors. Nature 356: 215-21.
2. Sah VP (1995) A subset of p53-deficient embryos exhibit exencephaly. Nature Genetics 10, 175-80.
3. de Oca Luna RM, Wagner DS, Lozano G (1995) Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 378: 203-6.
4. Jones SN, Roe AE, Donehower LA, BradleyA (1995) Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature 378: 206-8.
5. Choi J, Donehower LA (1999) p53 in embryonic development: maintaining a fine balance. Cell Mol Life Sci 55: 38-47.
6. Haupt Y, Maya R, Kazaz A, Oren M (1997) Mdm2 promotes the rapid degradation of p53. Nature 387, 296-9.
7. Grier JD, Xiong S, Elizondo-Fraire AC, Parant JM, Lozano G (2006) Tissue- Specific Differences of p53 Inhibition by Mdm2 and Mdm4. Molecular and Cellular Biology 26: 192.
8. Zhang Q (2012) Synergistic regulation of p53 by Mdm2 and Mdm4 is critical in cardiac endocardial cushion morphogenesis during heart development. J Pathol 228: 416-28.
9. Van Nostrand JL (2014) Inappropriate p53 activation during development induces features of CHARGE syndrome. Nature 514: 228-32.
10. Caprio C, Baldini A (2014) p53 suppression partially rescues the mutant phenotype in mouse models of DiGeorge syndrome. Proceedings of the National Academy of Sciences 111: 13385.
11. Morgan SC (2008) Cardiac outflow tract septation failure in Pax3-deficient embryos is due to p53-dependent regulation of migrating cardiac neural crest. Mechanisms of Development 125: 757-67.
12. Su D (2017) ROCK1/p53/NOXA signaling mediates cardiomyocyte apoptosis in response to high glucose in vitro and vivo. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1863: 936-46.
13. Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-76.
14. Takahashi K (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861-72.
15. Maimets T, Neganova I, Armstrong L, Lako M (2008) Activation of p53 by nutlin leads to rapid differentiation of human embryonic stem cells. Oncogene 27: 5277-87.
16. Molchadsky A, Rivlin N, Brosh R, Rotter V, Sarig R (2010) p53 is balancing development, differentiation and de-differentiation to assure cancer prevention. Carcinogenesis 31: 1501-8.
17. Yang A (2011) Nucleolin Maintains Embryonic Stem Cell Self-renewal by Suppression of p53 Protein-dependent Pathway. Journal of Biological Chemistry 286: 43370-82.
18. Dumitru R (2012) Human embryonic stem cells have constitutively active Bax at the Golgi and are primed to undergo rapid apoptosis. Mol Cell 46: 573-83.
19. Setoguchi K, TeSlaa T, Koehler CM, Teitell MA (2016) P53 Regulates Rapid Apoptosis in Human Pluripotent Stem Cells. Journal of Molecular Biology 428: 1465-75.
20. Qin H (2007) Regulation of apoptosis and differentiation by p53 in human embryonic stem cells. J Biol Chem 282: 5842-52.
21. Jain AK (2012) p53 regulates cell cycle and microRNAs to promote differentiation of human embryonic stem cells. PLoS Biol 10: e1001268.
22. Wang Q (2017) The p53 Family Coordinates Wnt and Nodal Inputs in Mesendodermal Differentiation of Embryonic Stem Cells. Cell Stem Cell 20: 70-86.
23. Hadjal Y, Hadadeh O, Yazidi CE, Barruet E, Binetruy BA (2013) p38MAPK-p53 cascade regulates mesodermal differentiation and neurogenesis of embryonic stem cells. Cell Death Dis 4: e737.
24. Moore IV JB (2016) The Epigenetic Regulator HDAC1 Modulates Transcription of a Core Cardiogenic Program in Human Cardiac Mesenchymal Stromal Cells Through a p53-Dependent Mechanism. STEM CELLS 34: 2916-29.
25. Vassilev LT ((2004) In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2. Science 303: 844.
26. Secreto FJ (2017) Quantification of Etoposide Hypersensitivity: A Sensitive, Functional Method for Assessing Pluripotent Stem Cell Quality. Stem cells translational medicine 6: 1829-39.
27. Perales-Clemente E (2016) Natural underlying mtDNA heteroplasmy as a potential source of intra-person hiPSC variability. The EMBO Journal 35: 1979-90.
28. Burridge PW, Holmström A, Wu JC (2015) Chemically Defined Culture and Cardiomyocyte Differentiation of Human Pluripotent Stem Cells. Curr Protoc Hum Genet 87: 21-3.
29. Kalari KR (2014) MAP-RSeq: Mayo Analysis Pipeline for RNA sequencing. BMC Bioinformatics 15: 224.
30. Szklarczyk D (2017) The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic acids research 45: D362-8.
31. Huang DW, Sherman BT, Lempicki RA (2008) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Research 37: 1-13.
32. Huang DW, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature Protocols 4: 44-57.
33. Li X (2014) Transcriptional atlas of cardiogenesis maps congenital heart disease interactome. Physiological Genomics 46, 482-95.
34. Kojic S (2015) Cardiac transcription factor Nkx2.5 interacts with p53 and modulates its activity. Arch Biochem Biophys 569: 45-53.
35. Budanov AV, Sablina AA, Feinstein E, Koonin EV, Chumakov PM (2004) Regeneration of Peroxiredoxins by p53-Regulated Sestrins, Homologs of Bacterial AhpD. Sci 304: 596.
36. Budanov AV, Karin M (2008) p53 Target Genes Sestrin1 and Sestrin2 Connect Genotoxic Stress and mTOR Signaling. Cell 134, 451-60.
37. Levine AJ, Feng Z, Mak TW, You H, Jin S (2006) Coordination and communication between the p53 and IGF-1–AKT–TOR signal transduction pathways. Genes & Development 20: 267-75.
38. Chung S (2007) Mitochondrial oxidative metabolism is required for the cardiac differentiation of stem cells. Nature Clinical Practice Cardiovascular Medicine 4: S60-7.
39. Puente Bao N (2014) The Oxygen-Rich Postnatal Environment Induces Cardiomyocyte Cell-Cycle Arrest through DNA Damage Response. Cell 157: 565-79.
40. Liu B, Chen Y, St Clair DK (2008) ROS and p53: A versatile partnership. Free Radical Biology and Medicine 44: 1529-35.
41. Mak TW, Hauck L, Grothe D, Billia F (2017) p53 regulates the cardiac transcriptome. Proc Natl Acad Sci U S A 114, 2331-6.
42. Hauck L (2017) Cardiac-specific ablation of the E3 ubiquitin ligase Mdm2 leads to oxidative stress, broad mitochondrial deficiency and early death. PLoS One 12: e0189861.
43. Xue R (2017) Sestrin 1 ameliorates cardiac hypertrophy via autophagy activation. J Cell Mol Med 21: 1193-205.
44. Dong B, Xue R, Sun Y, Dong Y, Liu C (2017) Sestrin 2 attenuates neonatal rat cardiomyocyte hypertrophy induced by phenylephrine via inhibiting ERK1/2. Molecular and Cellular Biochemistry 433: 113-23.
45. Li R (2019) Cardioprotective roles of sestrin 1 and sestrin 2 against doxorubicin cardiotoxicity. American Journal of Physiology-Heart and Circulatory Physiology 317: H39-48.